MeSH term
Frequency | Condition_Probility | Albumins/metabolism | 3 | 2.0 |
Albuminuria/*prevention & control | 3 | 3.0 |
Antihypertensive Agents/*therapeutic use | 3 | 1.0 |
Diabetes Mellitus, Type 2/complications/*drug therapy | 3 | 3.0 |
Humans | 61 | 0.0 |
Hypertension/complications/*drug therapy | 3 | 2.0 |
Indoles/*therapeutic use | 3 | 2.0 |
Renin-Angiotensin System/*drug effects | 3 | 2.0 |
Animals | 26 | 0.0 |
Cell Cycle/physiology | 2 | 0.0 |
Cell Cycle Proteins/genetics/metabolism | 2 | 2.0 |
Models, Biological | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 41 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Base Sequence | 10 | 0.0 |
CDC2 Protein Kinase/metabolism | 5 | 3.0 |
Cell Cycle | 8 | 0.0 |
*Cell Cycle Proteins | 29 | 2.0 |
Cell Division | 4 | 0.0 |
Cell Line | 8 | 0.0 |
Kinetics | 2 | 0.0 |
Mitosis | 8 | 1.0 |
Molecular Sequence Data | 16 | 0.0 |
*Nuclear Proteins | 30 | 1.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Transfection | 10 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 24 | 0.0 |
Apoptosis/*physiology | 2 | 0.0 |
Cell Compartmentation | 4 | 1.0 |
Male | 3 | 0.0 |
Mutation | 6 | 0.0 |
Protein Binding | 5 | 0.0 |
Protein Kinases/genetics/*metabolism | 3 | 3.0 |
Protein-Tyrosine Kinase/*metabolism | 7 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
14-3-3 Proteins | 3 | 2.0 |
Blotting, Western | 6 | 0.0 |
Catalysis | 2 | 0.0 |
G2 Phase | 7 | 4.0 |
Hela Cells | 13 | 0.0 |
Phosphorylation | 23 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Time Factors | 4 | 0.0 |
Cell Cycle Proteins/genetics/*metabolism | 3 | 2.0 |
Cell Line, Tumor | 3 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 3 | 0.0 |
Protein-Tyrosine Kinase/genetics/*metabolism | 7 | 5.0 |
DNA Damage | 5 | 0.0 |
G2 Phase/*drug effects/physiology | 2 | 50.0 |
Mice | 6 | 0.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Radiation-Sensitizing Agents/*pharmacology | 2 | 6.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
*CDC2-CDC28 Kinases | 4 | 0.0 |
Cyclin-Dependent Kinases/*metabolism | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 3 | 0.0 |
Tyrosine/metabolism | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Substrate Specificity | 5 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
*Ubiquitin-Protein Ligase Complexes | 3 | 4.0 |
G2 Phase/*drug effects | 3 | 9.0 |
Up-Regulation/drug effects | 3 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Comparative Study | 6 | 0.0 |
Protein-Tyrosine Kinase/*genetics | 2 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Antineoplastic Agents/*pharmacology | 4 | 0.0 |
G2 Phase/drug effects | 3 | 6.0 |
Mitosis/drug effects | 2 | 1.0 |
Cell Division/*drug effects | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Cycle/*physiology | 6 | 2.0 |
Plasmids | 2 | 0.0 |
Phosphoprotein Phosphatase/*metabolism | 2 | 2.0 |
DNA Primers | 2 | 0.0 |
Gene Expression Regulation, Fungal | 3 | 4.0 |
*Mitosis | 4 | 3.0 |
Mitosis/physiology | 4 | 4.0 |
Cell Cycle Proteins/metabolism | 3 | 0.0 |
Cyclins/*metabolism | 3 | 1.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 5 | 0.0 |
Phylogeny | 2 | 0.0 |
CDC2 Protein Kinase/*metabolism | 6 | 5.0 |
Cells, Cultured | 4 | 0.0 |
Cyclin B/metabolism | 3 | 3.0 |
Gene Expression/drug effects | 2 | 0.0 |
CDC2 Protein Kinase/*physiology | 2 | 18.0 |
Enzyme Activation | 5 | 0.0 |
Genetic Markers | 3 | 0.0 |
Genes, Fungal | 2 | 1.0 |
*Schizosaccharomyces pombe Proteins | 3 | 3.0 |
cdc25 Phosphatase | 6 | 12.0 |
Cell Cycle Proteins/*metabolism | 2 | 0.0 |
Protein-Tyrosine Kinase/genetics/metabolism | 3 | 4.0 |
G1 Phase/physiology | 2 | 2.0 |
Insects | 2 | 1.0 |
Protein Kinases/*metabolism | 3 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Cell Nucleus/enzymology | 2 | 2.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Ligases/genetics/*metabolism | 2 | 4.0 |
Chromosome Mapping | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Hamsters | 2 | 0.0 |
Homeostasis | 2 | 0.0 |
Phosphotyrosine | 2 | 0.0 |
Cyclin-Dependent Kinases/metabolism | 2 | 0.0 |
Cyclins/metabolism | 3 | 0.0 |
S Phase/physiology | 3 | 3.0 |
Schizosaccharomyces/enzymology/genetics | 2 | 28.0 |
Species Specificity | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
cdc25 Phosphatase/metabolism | 2 | 3.0 |
Adult | 2 | 0.0 |
Aged | 4 | 0.0 |
Female | 4 | 0.0 |
Middle Aged | 4 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
*Protein-Tyrosine Kinase | 3 | 0.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
Protein Kinases/*genetics | 2 | 1.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Mitosis/*genetics | 2 | 5.0 |
Cell Division/drug effects | 2 | 0.0 |
